FDA: phenytoin = NTID? [Regulatives / Guidelines]

posted by kvgreddy06 – India, 2014-09-26 16:17 (4287 d 15:01 ago) – Posting: # 13594
Views: 5,687

Hi Helmut,

❝ Do you have any references supporting your claim? FDA’s product specific guidances of 2008…


Recently we got a query from FDA.

FDA itself suggested “phenytoin is a narrow therapeutic index (NTI) drug, the Division of Bioequivalence currently recommends statistical analysis of bioequivalence study data using the reference-scaled average bioequivalence approach for NTI drugs as outlined in Warfarin guidance”


The OGD of phenytoin ER capsule is not available in current website, it was available in 2008.

Regards.
kvgr

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
125 visitors (0 registered, 125 guests [including 25 identified bots]).
Forum time: 07:18 CEST (Europe/Vienna)

Competence, like truth, beauty and contact lenses,
is in the eye of the beholder.    Laurence J. Peter

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5